Insider Cluster (3 insiders) ·Filed May 29, 2026

GH

Guardant Health, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago
Insider cluster: 3 insiders, $4.3M total
Actionable Insight • Neutral

The insider selling is negligible relative to market cap and carries no informational signal. Monitor for any material corporate events (earnings, M&A, regulatory decisions) that could explain the sales, but no immediate action warranted.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
GH ▲ +28.42% at T+60d
NEUTRAL call ✓ call won +28.42% · α vs SPY +27.45% · entry $128.42 → $164.92
Entry anchored
May 29, 2026
via day open
T+1d
+1.33%
call +1.33% · α +1.19%
$130.13
settled 4mo ago
T+5d
-2.19%
call -2.19% · α +0.56%
$125.61
settled 4mo ago
T+20d
+19.71%
call +19.71% · α +22.03%
$153.74
settled 3mo ago
T+60d
+28.42%
call +28.42% · α +27.45%
$164.92
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Three Guardant Health insiders, including the Chief Legal Officer and Chief Commercial Officer, sold a total of $4.28M in open-market sales over a 7-day window. The CCO's $2.9M sale is the largest, representing about 0.024% of the $17.7B market cap, which is trivial. The cluster is entirely sells with no buys, but the dollar amounts are immaterial relative to company size, and the sales are likely liquidity-driven or part of routine 10b5-1 plans.

Key Financial Metrics

Direction
selling
Total Value
$4.3M
Insiders
3

Key Facts

  • Three insiders sold a total of $4.28M in open-market sales from May 22-28, 2026.
  • Chief Commercial Officer Chris Freeman sold 24,400 shares for $2.90M at $118.67.
  • Chief Legal Officer John Saia sold 9,994 shares for $1.25M at $125.08.
  • Director Manuel Hidalgo Medina sold 1,000 shares for $130K at $130.06.
  • Total sales represent ~0.024% of Guardant Health's $17.7B market cap.
  • No insider purchases were reported in the cluster.

Financial Impact

Total insider sales of $4.28M, representing ~0.024% of market cap — immaterial.

insider selling volume

Risk Factors

  • Insider sales could be misinterpreted as bearish by retail traders despite being immaterial.
  • If the CCO's sale is part of a 10b5-1 plan, it is non-informative; if not, it may reflect personal liquidity needs.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
88% bullish (33 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-GH-1780090262229
26 reports for GH
Performance horizon
25% Hit rate 1 of 4 directional calls best @ T+60▲ +31.56%May 27, 2026
Filters
Rows
Reports for GH — sortable, filterable
TypeNow
Aug 24, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$163.18 $177.16▲ +8.57%▲ +7.25%$177.80 (+8.96%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$157.21 $167.84▲ +6.76%▲ +8.75%$177.80 (+13.10%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$157.21 $167.84▲ +6.76%▲ +8.75%$177.80 (+13.10%)
Aug 11, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$165.11 $159.03▼ −3.68%▼ −1.78%$177.80 (+7.69%)
Aug 11, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$165.11 $159.03▼ −3.68%▼ −1.78%$177.80 (+7.69%)
Aug 6, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$168.48 $161.41▼ −4.20%▼ −3.80%$177.80 (+5.53%)
Jul 30, 2026
9w ago
S-3ASR
NEUTRAL ★ 2/10
$161.99 $161.49▼ −0.31%▼ −3.29%$177.80 (+9.76%)
Jun 30, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$170.77 $144.07▼ −15.64%▼ −13.45%$177.80 (+4.12%)
Jun 22, 2026
14w ago
144
NEUTRAL ★ 2/10
$130.83 $148.07▲ +13.18%▲ +12.02%$177.80 (+35.90%)
Jun 16, 2026
15w ago
Court Ruling
BEARISH ★ 7/10
$127.34 $160.11▼ −25.73%▼ −25.53%$177.80 (−39.63%)
Showing 10 of 26

US Market Status

Market Closed — Opens Mon (64h 22m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 29, 2026